Company / EPS (Diluted)
4D Molecular Therapeutics, Inc. EPS (Diluted) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.98
FY2025
5-year range
-$8.82 / -$2.57
FY2021-FY2025
Trend
-15.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 6 years, ranging from $-9.59 in FY2020 to $-2.57 in FY2022.
Based on SEC 10-K filings.
-2.98 in FY2025.
Improved from $-3.32 to $-2.98 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 15.5% year-over-year.
- Peak eps (diluted) was recorded in FY2022.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.98 | -15.5% |
| FY2024 | -$2.58 | +22.3% |
| FY2023 | -$3.32 | -29.2% |
| FY2022 | -$2.57 | +70.9% |
| FY2021 | -$8.82 | +8.0% |
| FY2020 | -$9.59 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026